Watervein Partners
Watervein Partners is a venture capital firm based in Tokyo, Japan, established in 2002. The firm specializes in venture formation, focusing on selecting innovative biotech researchers from universities, research institutes, and industry networks. Watervein Partners provides comprehensive support throughout the startup process, aiming to transform these ventures into successful businesses. The firm adopts a hands-on investment approach, maintaining partial control while guiding companies toward profitable exits through initial public offerings or mergers and acquisitions. By concentrating on seed-stage investments, Watervein Partners seeks to foster the development of first-class enterprises in the biotechnology sector.
Anaeropharma Science, Inc. is a biopharmaceutical company based in Chiyoda, Japan, founded in 2004. The company specializes in the development of therapeutics aimed at treating solid cancers characterized by hypoxic environments. Utilizing its proprietary platform technology, which involves recombinant Bifidobacterium, Anaeropharma Science develops innovative solutions including APS001F for solid tumors, anticancer drugs in the immuno-oncology sector, and treatments for ischemia such as FGF2. The company's approach leverages genetically enhanced bacteria that thrive in the low-oxygen conditions typical of solid tumors, where they convert systemically administered pro-drugs into cytotoxic agents, thereby providing healthcare professionals with effective and safe therapeutic options for cancer and related hypoxic conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.